Advertisement

Abstract

Levovist, an intravenous ultrasonic contrast agent developed by Schering AG in Germany, is a mixture of 99.9% galactose and 0.1% palmitic acid. It is supplied as white granules or powder in vials. At the time of use, the granules are mixed with sterile water and energetically shaken to form a milk-white suspension that can be intravenously administered.

Keywords

Palmitic Acid Sterile Water Heat Sensation Cold Sensation Unusual Sensation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lankers M, Popp J, Roessling G, et al: Raman investigations on laser-trapped gas bubbles. Chem Phys Lett 1997; 277:331–334CrossRefGoogle Scholar

Copyright information

© Springer Japan 2003

Authors and Affiliations

  • Masatoshi Kudo
    • 1
  1. 1.Department of Gastroenterology and HepatologyKinki University School of MedicineOsakaJapan

Personalised recommendations